Premium
Cyclooxygenase regulates human oropharyngeal carcinomas via the proinflammatory cytokine IL‐6: a general role for inflammation?
Author(s) -
Hong Sung H.,
Ondrey Frank G.,
Avis Ingalill M.,
Chen Zhong,
Loukinova Elena,
Cavanaugh Paul F.,
Van Waes Carter,
Mulshine James L.
Publication year - 2000
Publication title -
the faseb journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.709
H-Index - 277
eISSN - 1530-6860
pISSN - 0892-6638
DOI - 10.1096/fj.99-0802com
Subject(s) - cytokine , proinflammatory cytokine , inflammation , cyclooxygenase , cell culture , cancer research , chemistry , paracrine signalling , cell growth , autocrine signalling , receptor , biology , microbiology and biotechnology , medicine , immunology , biochemistry , enzyme , genetics
High levels of prostaglandins are produced in human oropharyngeal carcinoma (OPC). Five human OPC cell lines tested expressed both isoforms of cyclooxygenases (COX). The pan‐COX inhibitor ketorolac continuously and significantly decreased PGE 2 production and IL‐6 and IL‐8 levels in all OPC cell lines tested, but did not affect IL‐1a, GM‐CSF levels, or in vitro tumor cell growth. In contrast, ketorolac reduced OPC growth in vivo. The OPC cell lines used express the IL‐6 receptor, and IL‐6 stimulation of these cells causes transduction to occur via STAT3 pathway activation. Coincubation with OPC cell lines with conditioned medium from a TPA‐exposed HL‐60 cells stimulated growth proportional to the IL‐6 levels measured in the conditioned medium. This growth effect was specifically inhibited by anti‐IL‐6 antibody. These results are consistent with cytokine products of inflammatory cells having paracrine growth effects on OPC. If chronic inflammation plays a role in promoting the development of OPC, this mechanism may also apply to other epithelial tumor systems modulated by COX activity.–Hong, S. H., Ondrey, F. G., Avis, I. M., Chen, Z., Loukinova, E., Cavanaugh, P. F., Jr., Van Waes, C., Mulshine, J. L. Cyclooxygenase regulates human oropharyngeal carcinomas via the proinflammatory cytokine IL‐6: a general role for inflammation?. FASEB J. 14, 1499–1507 (2000)